Chemotherapy in the management of squamous-cell carcinoma of the head and neck

This publication has 48 references indexed in Scilit:

• Natural history of untreated head and neck cancer
  European Journal Of Cancer, 2000
• A phase II study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neck
  British Journal of Cancer, 1999
• Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck
  Cancer, 1998
• Clinical phase II evaluation of paclitaxel in combination with cisplatin in metastatic or recurrent squamous cell carcinoma of the head and neck
  Annals of Oncology, 1998
• Chemotherapy for symptom control in recurrent squamous cell carcinoma of the head and neck
  Annals of Oncology, 1997
• Docetaxel: an active drug for squamous cell carcinoma of the head and neck.
  Journal of Clinical Oncology, 1996
• Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck
  Annals of Oncology, 1994
• Docetaxel (Taxotere®): An active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck
  Annals of Oncology, 1994
• Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.
  Journal of Clinical Oncology, 1992
• A phase III randomised trial of cisplatinum, methotrextate, cisplatinum + methotrexate and cisplatinum + 5-FU in end stage squamous carcinoma of the head and neck
  British Journal of Cancer, 1990